Gsa Capital Partners LLP Concert Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.69 - $4.22 $1.02 Million - $1.6 Million	-379,244 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.17 - $4.15 $312,672 - $409,335	98,635 Added 35.15%	379,244 $1.24 Million
Q2 2021 Aug 05, 2021	BUY	$3.77 - $5.24 $612,097 - $850,766	162,360 Added 137.3%	280,609 $1.18 Million
Q1 2021 May 10, 2021	BUY	$4.86 - $13.07 $226,582 - $609,349	46,622 Added 65.09%	118,249 $590,000
Q4 2020 Feb 03, 2021	BUY	$9.48 - $12.84 $128,283 - $173,750	13,532 Added 23.29%	71,627 $905,000
Q3 2020 Nov 06, 2020	BUY	$8.67 - $10.82 $353,250 - $440,850	40,744 Added 234.82%	58,095 $570,000
Q2 2020 Aug 11, 2020	BUY	$7.8 - $11.52 $135,337 - $199,883	17,351 New	17,351 $173,000
Q1 2020 May 12, 2020	SELL	$5.98 - $13.09 $290,418 - $635,715	-48,565 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$5.71 - $9.22 $71,203 - $114,973	12,470 Added 34.55%	48,565 $448,000
Q3 2019 Nov 12, 2019	BUY	$5.88 - $12.35 $212,238 - $445,773	36,095 New	36,095 $212,000
Q2 2019 Aug 06, 2019	SELL	$9.44 - $13.12 $706,300 - $981,638	-74,820 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $230,295 - $334,663	-19,080 Reduced 20.32%	74,820 $903,000
Q4 2018 Feb 12, 2019	SELL	$11.25 - $16.17 $873,000 - $1.25 Million	-77,600 Reduced 45.25%	93,900 $1.18 Million
Q3 2018 Nov 13, 2018	BUY	$12.82 - $17.88 $612,796 - $854,664	47,800 Added 38.64%	171,500 $2.55 Million
Q2 2018 Aug 09, 2018	BUY	$16.83 - $21.66 $2.08 Million - $2.68 Million	123,700 New	123,700 $2.08 Million
Q1 2018 May 11, 2018	SELL	$19.24 - $28.03 $1.33 Million - $1.94 Million	-69,300 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $967,428 - $2.01 Million	69,300	69,300 $1.79 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account